269 related articles for article (PubMed ID: 11325810)
1. Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels.
Song DK; Ashcroft FM
Br J Pharmacol; 2001 May; 133(1):193-9. PubMed ID: 11325810
[TBL] [Abstract][Full Text] [Related]
2. Effects of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and Kir6.2/SUR2B types of ATP-sensitive potassium channel.
Reimann F; Proks P; Ashcroft FM
Br J Pharmacol; 2001 Apr; 132(7):1542-8. PubMed ID: 11264248
[TBL] [Abstract][Full Text] [Related]
3. Effect of metabolic inhibition on glimepiride block of native and cloned cardiac sarcolemmal K(ATP) channels.
Lawrence CL; Rainbow RD; Davies NW; Standen NB
Br J Pharmacol; 2002 Jul; 136(5):746-52. PubMed ID: 12086984
[TBL] [Abstract][Full Text] [Related]
4. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
Dabrowski M; Wahl P; Holmes WE; Ashcroft FM
Diabetologia; 2001 Jun; 44(6):747-56. PubMed ID: 11440368
[TBL] [Abstract][Full Text] [Related]
5. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
Gribble FM; Tucker SJ; Seino S; Ashcroft FM
Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
[TBL] [Abstract][Full Text] [Related]
6. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
Cui Y; Tinker A; Clapp LH
Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the differential modulation of sulphonylurea block of beta-cell and cardiac ATP-sensitive K+ (K(ATP)) channels by Mg-nucleotides.
Reimann F; Dabrowski M; Jones P; Gribble FM; Ashcroft FM
J Physiol; 2003 Feb; 547(Pt 1):159-68. PubMed ID: 12562963
[TBL] [Abstract][Full Text] [Related]
8. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
[TBL] [Abstract][Full Text] [Related]
9. Cardioselectivity of the sulphonylurea HMR 1098: studies on native and recombinant cardiac and pancreatic K(ATP) channels.
Manning Fox JE; Kanji HD; French RJ; Light PE
Br J Pharmacol; 2002 Jan; 135(2):480-8. PubMed ID: 11815384
[TBL] [Abstract][Full Text] [Related]
10. Gliclazide produces high-affinity block of KATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells.
Lawrence CL; Proks P; Rodrigo GC; Jones P; Hayabuchi Y; Standen NB; Ashcroft FM
Diabetologia; 2001 Aug; 44(8):1019-25. PubMed ID: 11484080
[TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity of beta-cell and extrapancreatic K(ATP) channels to gliclazide.
Gribble FM; Ashcroft FM
Diabetologia; 1999 Jul; 42(7):845-8. PubMed ID: 10440127
[TBL] [Abstract][Full Text] [Related]
12. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
Dörschner H; Brekardin E; Uhde I; Schwanstecher C; Schwanstecher M
Mol Pharmacol; 1999 Jun; 55(6):1060-6. PubMed ID: 10347249
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the interference between nicorandil and sulfonylurea action.
Reimann F; Ashcroft FM; Gribble FM
Diabetes; 2001 Oct; 50(10):2253-9. PubMed ID: 11574406
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the n-terminus of Kir6.2 in coupling to the sulphonylurea receptor.
Reimann F; Tucker SJ; Proks P; Ashcroft FM
J Physiol; 1999 Jul; 518 ( Pt 2)(Pt 2):325-36. PubMed ID: 10381582
[TBL] [Abstract][Full Text] [Related]
15. Taurine block of cloned ATP-sensitive K+ channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes.
Lim JG; Lee HY; Yun JE; Kim SP; Park JW; Suh SI; Jang BC; Cho CH; Bae JH; Kim SS; Han J; Park MJ; Song DK
Biochem Pharmacol; 2004 Sep; 68(5):901-10. PubMed ID: 15294453
[TBL] [Abstract][Full Text] [Related]
16. Potent and selective activation of the pancreatic beta-cell type K(ATP) channel by two novel diazoxide analogues.
Dabrowski M; Larsen T; Ashcroft FM; Bondo Hansen J; Wahl P
Diabetologia; 2003 Oct; 46(10):1375-82. PubMed ID: 12961066
[TBL] [Abstract][Full Text] [Related]
17. The novel diazoxide analog 3-isopropylamino-7-methoxy-4H-1,2,4-benzothiadiazine 1,1-dioxide is a selective Kir6.2/SUR1 channel opener.
Dabrowski M; Ashcroft FM; Ashfield R; Lebrun P; Pirotte B; Egebjerg J; Bondo Hansen J; Wahl P
Diabetes; 2002 Jun; 51(6):1896-906. PubMed ID: 12031979
[TBL] [Abstract][Full Text] [Related]
18. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
[TBL] [Abstract][Full Text] [Related]
19. Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
Ashfield R; Gribble FM; Ashcroft SJ; Ashcroft FM
Diabetes; 1999 Jun; 48(6):1341-7. PubMed ID: 10342826
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide modulation of pinacidil stimulation of the cloned K(ATP) channel Kir6.2/SUR2A.
Gribble FM; Reimann F; Ashfield R; Ashcroft FM
Mol Pharmacol; 2000 Jun; 57(6):1256-61. PubMed ID: 10825398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
